ARCHIVES

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Continues Making Improvements In Contract Management

May 22, 1981

UCSF AIDS, Cancer Specimen Resource Bank Funded, Renamed

November 15, 2002

NCI Sets its Targets for Grant Success Rate and R01 Payline for FY05.

January 21, 2005

Majority Of Americans Would Consider Participating In Clinical Trials, Study Finds

March 28, 2003

Adjuvant Nutrition Breast Cancer Study Offered To Groups

March 19, 1982

In Brief: Harvard’s Richmond Said To Be The Choice As Asst. secretary; Lee Clark Convalescing

May 6, 1977